Recipient immune repertoire and engraftment site influence the immune pathway effecting acute hepatocellular allograft rejection

Cell Transplantation

Volumn 17, Issue 7, 2008, Pages 829-844

  Horne, Phillip H ^a   Lunsford, Keri E ^a   Walker, Jon P ^a   Koester, Mitchel A ^a   Bumgardner, Ginny L ^a,b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Alloantibody; Cell transplantation; Cytotoxicity; Delayed type hypersensitivity (DTH); Engraftment site

Indexed keywords

ALLOANTIBODY;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CELLULAR IMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOLYSIS; CYTOTOXICITY; DELAYED HYPERSENSITIVITY; DONOR; ENGRAFTMENT; GRAFT RECIPIENT; HOST; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOTHERAPY; KIDNEY; KINETICS; LIVER; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MONITORING; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; ALLOTRANSPLANTATION; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CYTOLOGY; GRAFT REJECTION; HUMAN; IMMUNOLOGY; LIVER CELL; PATHOLOGY; TRANSGENIC MOUSE; TRANSPLANTATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; GRAFT REJECTION; HEPATOCYTES; HUMANS; IMMUNE SYSTEM; KIDNEY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, IMMUNOLOGICAL; TRANSPLANTATION, HOMOLOGOUS;

EID: 58149182928     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368908786516792     Document Type: Article

References (46)

1. Abrams, J.; Amir, O.; Etheridge, W. B.; Frazier, O. H. Histologic findings proving the existence of humoral rejection in a cardiac allograft. Cardiovasc. Pathol. 16(1): 38-42; 2007.
2. + cells and CD40-CD40 Ligand interactions. J. Immunol. 166(5):3248-3255; 2001.
3. Bumgardner, G. L. Evidence for multiple allograft rejection mechanisms within the same experimental system. Curr. Opin. Organ Transplant. 10:20-27; 2005.
4. Bumgardner, G. L.; Gao, D.; Li, J.; Baskin, J.; Heininger, M.; Orosz, C. G. Rejection responses to allogeneic hepatocytes by reconstituted SCID mice, CD4 KO, and CD8 KO mice. Transplantation 70(12):1771-1780; 2000.
5. Bumgardner, G. L.; Heininger, M.; Li, J.; Xia, D.; Parker-Thornburg, J.; Ferguson, R. M.; Orosz, C. G. A functional model of hepatocyte transplantation for in vivo immunologic studies. Transplantation 65(1):53-61; 1998.
6. Bumgardner, G. L.; Li, J.; Heininger, M.; Orosz, C. G. Costimulation pathways in host immune responses to allogeneic hepatocytes. Transplantation 66(12):1841-1845; 1998.
7. + T-cell responses in acute rejection. Transplantation 68(4):555-562; 1999.
8. Bumgardner, G. L.; Orosz, C. G. Unusual patterns of alloimmunity evoked by allogeneic liver parenchymal cells. Immunol. Rev. 174:260-279; 2000.
9. Carding, S. R.; Egan, P. J. Gammadelta T cells: Functional plasticity and heterogeneity. Nat. Rev. Immunol. 2(5):336-345; 2002.
10. Chen, L.; Wang, T.; Zhou, P.; Ma, L.; Yin, D.; Shen, J.; Molinero, L.; Nozaki, T.; Phillips, T.; Uematsu, S.; Akira, S.; Wang, C. R.; Fairchild, R. L.; Alegre, M. L.; Chong, A. TLR engagement prevents transplantation tolerance. Am. J. Transplant. 6(10):2282-2291; 2006.
11. Choi, J.; Cho, Y. M.; Yang, W. S.; Park, T. J.; Chang, J. W.; Park, S. K. Peritubular capillary C4d deposition and renal outcome in post-transplant IgA nephropathy. Clin. Transplant. 21(2):159-165; 2007.
12. Coudert, J. D.; Coureau, C.; Guery, J. C. Preventing NK cell activation by donor dendritic cells enhances allospecific CD4 T cell priming and promotes Th type 2 responses to transplantation antigens. J. Immunol. 169(6): 2979-2987; 2002.
13. Crispe, I. N.; Dao, T.; Klugewitz, K.; Mehal, W. Z.; Metz, D. P. The liver as a site of T-cell apoptosis: graveyard, or killing field? Immunol. Rev. 174:47-62; 2000.
14. Crispe, I. N.; Mehal, W. Z. Strange brew: T cells in the liver. Immunol. Today 17(11):522-531; 1996.
15. + T cells: There's more to it than MHC restriction. Am. J. Transplant. 3(2): 107-115; 2003.
16. Durante-Mangoni, E.; Wang, R.; Shaulov, A.; He, Q.; Nasser, I.; Afdhal, N.; Koziel, M. J.; Exley, M. A. Hepatic CDld expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells. J. Immunol. 173(3):2159-2166; 2004.
17. Feng, Y.; Wang, D.; Yuan, R.; Parker, C. M.; Farber, D. L.; Hadley, G. A. CD103 expression is required for destruction of pancreatic islet allografts by CD8+ T cells. J. Exp. Med. 196(7):877-886; 2002.
18. + cells that independently initiate rejection of allogeneic hepatocytes in mice. Hepatology 32(5):1018-1028; 2000.
19. + T cells in allograft acceptance induced by DST and CD40/CD154 costimulatory blockade. Am. J. Transplant. 4(7):1061-1070; 2004.
20. Gao, Y.; Yang, W.; Pan, M.; Scully, E.; Girardi, M.; Augenlicht, L. H.; Craft, J.; Yin, Z. Gamma delta T cells provide an early source of interferon gamma in tumor immunity. J. Exp. Med. 198(3):433-442; 2003.
21. Hadley, G. Role of integrin CD103 in promoting destruction of renal allografts by CDS T cells. Am. J. Transplant. 4(7): 1026-1032; 2004.
22. Herkel, J.; Jagemann, B.; Wiegard, C.; Lazaro, J. F.; Lueth, S.; Kanzler, S.; Blessing, M.; Schmitt, E.; Lohse, A. W. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocytes. Hepatology 37(5):1079-1085; 2003.
23. + T cells. J. Immunol. 179(1):80-88; 2007.
24. + T-cell-dependent immune damage of liver parenchymal cells is mediated by alloantibody. Transplantation 80(4):514-521; 2005.
25. Jones, T. R.; Ha, J.; Williams, M. A.; Adams, A. B.; Durham, M. M.; Rees, P. A.; Cowan, S. R.; Pearson, T. C.; Larsen, C. P. The role of the IL-2 pathway in costim-ulation blockade-resistant rejection of allografts. J. Immunol. 168(3):1123-1130; 2002.
26. Kean, L. S.; Hamby, K.; Koehn, B.; Lee, E.; Coley, S.; Stempora, L.; Adams, A. B.; Heiss, E.; Pearson, T. C.; Larsen, C. P. NK cells mediate costimulation blockade-resistant rejection of allogeneic stem cells during nonmyeloablative transplantation. Am. J. Transplant. 6(2):292-304; 2006.
27. Le Moine, A.; Goldman, M. Non-classical pathways of cell-mediated allograft rejection: New challenges for tolerance induction? Am. J. Transplant. 3(2):101-106; 2003.
28. Lunsford, K. E.; Gao, D.; Eiring, A. M.; Wang, Y.; Frankel, W. L.; Bumgardner, G. L. Evidence for tissue directed immune responses: Analysis of CD4-dependent and CD8-dependent alloimmunity. Transplantation 78(8):1125-1133; 2004.
29. Lunsford, K. E.; Home, P. H.; Koester, M. A.; Eiring, A. M.; Walker, J. P.; Dziema, H. L.; Bumgardner, G. L. Activation and maturation of alloreactive CD4-independent, CD8 cytolytic T cells. Am. J. Transplant. 6(10): 2268-2281; 2006.
30. + T cells. J. Immunol. 175(12):7855-7866; 2005.
31. Mauiyyedi, S.; Crespo, M.; Collins, A. B.; Schneeberger, E. E.; Pascual, M. A.; Saidman, S. L.; Tolkoff-Rubin, N. E.; Williams, W. W.; Delmonico, F. L.; Cosimi, A. B.; Colvin, R. B. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J. Am. Soc. Nephrol. 13(3):779-787; 2002.
32. Miura, M.; El-Sawy, T.; Fairchild, R. L. Neutrophils mediate parenchymal tissue necrosis and accelerate the rejection of complete major histocompatibility complex-disparate cardiac allografts in the absence of interferon-gamma. Am. J. Pathol. 162(2):509-519; 2003.
33. + T cell immune response against Encephalitozoon cuniculi infection. J. Immunol. 166(12):7389-7397; 2001.
34. + T cells. J. Immunol. 163(5):2358-2362; 1999.
35. Ninomiya, T.; Takimoto, H.; Matsuzaki, G.; Hamano, S.; Yoshida, H.; Yoshikai, Y.; Kimura, G.; Nomoto, K. Vgammal+ gammadelta T cells play protective roles at an early phase of murine cytomegalovirus infection through production of interferon-gamma. Immunology 99(2): 187-194; 2000.
36. Nomi, H.; Tashiro-Yamaji, J.; Miura-Takeda, S.; Shimizu, T.; Azuma, H.; Ueda, H.; Katsuoka, Y.; Kubota, T.; Yoshida, R. Infiltration of H-2(d)-specific cytotoxic macrophage with unique morphology into rejection site of allografted Meth A (H-2(d)) tumor cells in C57BL/6 (H-2(b)) mice. Microbiol. Immunol. 51(3):297-306; 2007.
37. Oehen, S.; Brduscha-Riem, K. Differentiation of naive CTL to effector and memory CTL: Correlation of effector function with phenotype and cell division. J. Immunol. 161(10):5338-5346; 1998.
38. Ohashi, K.; Kay, M. A.; Kuge, H.; Yokoyama, T.; Kanehiro, H.; Hisanaga, M.; Ko, S.; Nagao, M.; Sho, M.; Nakajima, Y. Heterotopically transplanted hepatocyte survival depends on extracellular matrix components. Transplant. Proc. 37(10):4587-4588; 2005.
39. Ohashi, K.; Kay, M. A.; Yokoyama, T.; Kuge, H.; Kanehiro, H.; Hisanaga, M.; Ko, S.; Nakajima, Y. Stability and repeat regeneration potential of the engineered liver tissues under the kidney capsule in mice. Cell Transplant. 14(9):621-627; 2005.
40. Ohashi, K.; Waugh, J. M.; Dake, M. D.; Yokoyama, T.; Kuge, H.; Nakajima, Y.; Yamanouchi, M.; Naka, H.; Yoshioka, A.; Kay, M. A. Liver tissue engineering at extrahepatic sites in mice as a potential new therapy for genetic liver diseases. Hepatology 41:132-140; 2005.
41. Salama, A. D.; Womer, K. L.; Sayegh, M. H. Clinical transplantation tolerance: many rivers to cross. J. Immunol. 178(9):5419-5423; 2007.
42. Terasaki, P. I.; Cai, J. Humoral theory of transplantation: Further evidence. Curr. Opin. Immunol. 17(5):541-545; 2005.
43. + lymphocytes in renal allografts are associated with poor graft survival in pediatric patients. Transplantation 82(12):1769-1773; 2006.
44. + T lymphocyte responses. Nat. Immunol. 4(4):361-365; 2003.
45. + T cells in cyclosporin A immunosuppressed mice. Transpl. Immunol. 15(1):35-44; 2005.
46. Winau, F.; Hegasy, G.; Weiskirchen, R.; Weber, S.; Cassan, C.; Sieling, P. A.; Modlin, R. L.; Liblau, R. S.; Gressner, A. M.; Kaufmann, S. H. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 26(1):117-129; 2007.